Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beren H Tomooka

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2013
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosisKeith Van Haren, Beren H Tomooka, Brian A Kidd, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune diseasePeggy P Ho, Paulo Fontoura, Michael Platten, et al.
The Journal of Clinical Investigation|September 19, 2006
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritisRicardo T Paniagua, Orr Sharpe, Peggy P Ho, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2013
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosisKeith Van Haren, Beren H Tomooka, Brian A Kidd, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune diseasePeggy P Ho, Paulo Fontoura, Michael Platten, et al.
The Journal of Clinical Investigation|September 19, 2006
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritisRicardo T Paniagua, Orr Sharpe, Peggy P Ho, et al.
Pageof 2